Implementation of a qSOFA Score in the Emergency Department (qSOFA2)
Primary Purpose
Sepsis
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
emergency vital room
box
Sponsored by
About this trial
This is an interventional screening trial for Sepsis focused on measuring screening, qSOFA, sepsis, Emergency care unit
Eligibility Criteria
Inclusion Criteria:
- body temperature below 36 °C or above 38 °C
- require hospitalization
Exclusion Criteria:
- hospital transfer,
- patients with pre hospital care
- language barrier,
- refusal to participate
Sites / Locations
- Chu BesanconRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
patients with qSOFA ≥ 2
patients with qSOFA <2
Arm Description
adult patients with a qSOFA score ≥ 2 at the screening in the emergency department, will be referred to the emergency vital room
adult patients with a qSOFA score < 2 at the screening in the emergency department, will be referred to the box
Outcomes
Primary Outcome Measures
mortality rate
compare mortality rate with orientation in emergency
Secondary Outcome Measures
support time to medical contact
compare support time with orientation of patients according to the orientation of the patient in the emergency department
support time to initiation of antibiotics
compare support time with initiation antibiotics of patients according to the orientation of the patient in the emergency department
Full Information
NCT ID
NCT04568746
First Posted
September 24, 2020
Last Updated
October 15, 2020
Sponsor
Centre Hospitalier Universitaire de Besancon
1. Study Identification
Unique Protocol Identification Number
NCT04568746
Brief Title
Implementation of a qSOFA Score in the Emergency Department
Acronym
qSOFA2
Official Title
Impact of the Implementation of a qSOFA Score on the Care of Adult Patients Referred to the Emergency Department for Suspected Infection
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 12, 2020 (Actual)
Primary Completion Date
September 30, 2021 (Anticipated)
Study Completion Date
November 1, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Besancon
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The Quick-SOFA score (qSOFA), identifies septic patients with a mortality risk higher than 10%. In our study all adult patients coming to the emergency for suspected infection are screened according to the qSOFA score on arrival. If qSOFA ≥ 2, the patient should be referred to emergency vital room, if the score <2, the patient will be in the box. The objectives are : 1) to evaluate the mortality at 28 days with the orientation, 2) to compare support time of medical contact and initiation of antibiotics according to the orientation in the emergency department.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sepsis
Keywords
screening, qSOFA, sepsis, Emergency care unit
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
190 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
patients with qSOFA ≥ 2
Arm Type
Other
Arm Description
adult patients with a qSOFA score ≥ 2 at the screening in the emergency department, will be referred to the emergency vital room
Arm Title
patients with qSOFA <2
Arm Type
Other
Arm Description
adult patients with a qSOFA score < 2 at the screening in the emergency department, will be referred to the box
Intervention Type
Procedure
Intervention Name(s)
emergency vital room
Intervention Description
At the arrival of the patient, the qSOFA will be carried out to guide the orientation. Patient with score ≥ 2 will be supported in emergency vital room
Intervention Type
Procedure
Intervention Name(s)
box
Intervention Description
patient with score < 2 will be supported in box
Primary Outcome Measure Information:
Title
mortality rate
Description
compare mortality rate with orientation in emergency
Time Frame
28 days
Secondary Outcome Measure Information:
Title
support time to medical contact
Description
compare support time with orientation of patients according to the orientation of the patient in the emergency department
Time Frame
1 day
Title
support time to initiation of antibiotics
Description
compare support time with initiation antibiotics of patients according to the orientation of the patient in the emergency department
Time Frame
1 day
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
body temperature below 36 °C or above 38 °C
require hospitalization
Exclusion Criteria:
hospital transfer,
patients with pre hospital care
language barrier,
refusal to participate
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mathilde BOISTON
Phone
033381668951
Email
mboiston@chu-besancon.fr
Facility Information:
Facility Name
Chu Besancon
City
Besançon
ZIP/Postal Code
25000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mathilde BOISTON
Email
mboiston@chu-besancon.fr
First Name & Middle Initial & Last Name & Degree
Tania MARX
Phone
033381668162
Email
tmarx@chu-besancon.fr
12. IPD Sharing Statement
Learn more about this trial
Implementation of a qSOFA Score in the Emergency Department
We'll reach out to this number within 24 hrs